21 May 2013
Keywords: Karo Bio, Eprotirone, Split up, Cholesterol lowerer
Article | 15 February 2012
There was a double-dose of bad news for Sweden’s Karo Bio (STO: KARO), which this week said it ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 February 2012
20 May 2013
© 2013 thepharmaletter.com